Efficacy of Intermittent Tiotropium in Early Childhood Wheezing

Status Completed

Clinical Trial Summary

This study evaluates the effect of intermittent tiotropium bromide and salbutamol as needed versus intermittent fluticasone propionate and salbutamol as needed, or solely, salbutamol as needed on episode-free days in infants and toddlers with recurrent episodes of wheeze and/or shortness of breath.

Clinical Trial Description

Up to 30% of all children suffer from episodic wheeze or shortness of breath, i.e. asthmatic bronchitis, during the first three years of life. The condition is usually induced by viral respiratory infections, and short-acting beta-agonists are recommended as a monotherapy for symptoms unless there are at least four physician-confirmed episodes of wheeze or shortness of breath, or three episodes plus asthma risk factors. There is a current need for new therapeutic agents to treat asthmatic bronchitis in young children. In viral-induced wheeze, increased parasympathetic nerve activity results in increased acethylcholine release from nerve endings. Tiotropium bromide, an inhaled anticholinergic agent, prevents the acetylcholine function and achieves mild bronchodilatation and decrease in mucus secretion from the submucosal glands. The aim of the study is to find out the effect of intermittent tiotropium bromide and salbutamol as needed versus intermittent fluticasone propionate and salbutamol as needed, or solely, salbutamol as needed on episode-free days in infants and toddlers with recurrent episodes of wheeze and/or shortness of breath. Episode-free days are defined as those days during which there are no symptoms of wheeze and/or shortness of breath, no unscheduled medical visits for wheeze and/or shortness of breath, and no use of rescue or supplementary controller medications. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03199976
Study type	Interventional
Source	Helsinki University Central Hospital
Contact
Status	Completed
Phase	Phase 4
Start date	April 20, 2016
Completion date	November 18, 2020

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT04669288` - AZithromycin Therapy in Preschoolers With a Severe Wheezing Episode Diagnosed at the Emergency Department	Phase 3
Withdrawn	`NCT04584034` - Bronchodilators for Wheeze in Young Children Presenting to Primary Care: a Randomised, Placebo-controlled, Multicentre, Parallel Group Trial	Phase 4
Terminated	`NCT02269761` - Chest Ultrasound of ER Patients With Cough or SOB
Enrolling by invitation	`NCT00775697` - Montelukast in Children With Wheezing	Phase 4
Completed	`NCT00749528` - Evaluation of Toxic Metals, Trace Elements and Total Antioxidant Activity in Children With Recurrent Wheezing	N/A
Recruiting	`NCT00494624` - Efficacy of Systemic Glucocorticoid in the Treatment of Wheezing in Children	Phase 4
Recruiting	`NCT04128592` - Non-invasive Differential Diagnosis of Noisy Breathing Infants and Toddlers	N/A
Recruiting	`NCT06093152` - Video Assisted Study of Salbutamol Response in Viral Wheezing
Completed	`NCT01452945` - Bedside Lung Ultrasound in Young Children Presenting to the Emergency Department (ED) With Wheezing	N/A
Withdrawn	`NCT00628303` - A Phase 3 Trial of the Effect of Motavizumab Prophylaxis on Reduction of Serious Early Childhood Wheezing in Infants	Phase 3
Completed	`NCT01028560` - Allergy Immunotherapy for the Reduction of Asthma	Phase 1/Phase 2
Completed	`NCT00626808` - A Post Marketing Evaluation of the Effectiveness of FluMist Risk Minimization Plan in Children	Phase 4
Completed	`NCT00507676` - Lung Function and Structure in Healthy Infants and Infants With Recurrent Wheezing	N/A
Completed	`NCT03600428` - Safety of LAIV4 in Children With Asthma	Phase 4
Recruiting	`NCT06106646` - Vitamin C to Decrease Effects of Smoking in Pregnancy on Infant Lung Function (VCSIP) Longer Term Follow Up
Recruiting	`NCT05710081` - Bacterial Lysate In Preventing Asthma	Phase 3
Completed	`NCT04011709` - A Methodology Trial Using the VR647 Inhalation System in Pediatric Subjects Who Have Previously Received Inhaled Therapy	Early Phase 1
Active, not recruiting	`NCT03377192` - Impedance Pneumography in Assessment of Asthma Control in Preschool Children
Completed	`NCT01142505` - Wheeze and Intermittent Treatment	Phase 3
Active, not recruiting	`NCT04942483` - Using Specific Tests in Preschool Children With Wheeze to Help us Determine the Necessity of Inhaled Corticosteroid Therapy (Feasibility Study).